Posts Tagged ‘patient recruitment’

The continuous innovation of technology is changing the way companies operate across different sectors. In particular, big data and artificial intelligence (AI) are expected to have the most significant impact. In this post, we’ll discuss how big data and AI can be used to support clinical trials in a variety of ways. How does big […]

Clinical Leader recently published an article in which the author and a representative of Pfizer made some really interesting points about the role of treating physicians in clinical subject recruitment. The typical approach to recruitment is to target patients directly. On the surface, this approach may seem patient- or customer-centric, but when you look a […]

Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. How Merck & Facebook Are […]

In December 2016, my colleague wrote about various technologies that can help pharmaceutical and research organizations help recruit clinical trial subjects. One of the applications Param Singh, our director of clinical operations and connected health for life sciences, highlighted is called Antidote Match: “Antidote Match, which uses natural language processing, artificial intelligence, and an army […]

In the area of subject recruitment, there are several new technologies that focus on making it easier for companies to recruit, such as reaching a wider population directly for recruitment. Initially, recruitment was handled mostly by physicians and their patients; however reaching patients directly is proving to be very fruitful. One example of a company […]

  As we mentioned in our life sciences trends guide for 2016, patient recruitment is a constant challenge that needs to be confronted head-on with innovative tactics and technology. The mere fact that only 5% of cancer patients ever enroll in a trial is simply unacceptable, considering how connected we are in the digital era. 

  Clinical trials face long delays and, in some cases, are even cancelled because too few subjects are enrolled. Sponsors and CROs have different recruitment strategies, from advertising through mainstream media (although this practice is not as widespread you’d think) to the use of mobile and digital applications. But, one of the most effective ways […]

  Over the last decade, the life sciences industry has gone from running clinical trials on paper or, in many cases, in Excel, to leveraging comprehensive web-based systems, such as electronic data capture (EDC) and clinical trial management systems (CTMS). But, in more recent years, the widespread use of mobile technology has enabled even more […]

  Now that November is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in October – they’re ranked in order of popularity, with number one being the most viewed piece. 

  I’ve written a number of blog posts on the challenges of clinical trial recruitment, and that’s for good reason. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever complete […]

  Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. 

  I’m sitting at my desk thinking to myself: Why don’t I see many ads trying to recruit patients for clinical trials? “Many” is actually an overstatement. I rarely see them. Anywhere. And that’s a problem. I’m fairly healthy, but I have some issues. I’m slowing balding. I suffer from heartburn. Sometimes, I have debilitating […]